AAPG · Categories · Form 4
AAPG - SEC Form 4 insider transactions
Ascentage Pharma Group International (AAPG) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for AAPG
- Chief Medical Officer Zhai Yifan converted options into 188,321 units of Ordinary Shares, increasing direct ownership by 30% to 405,280 units (SEC Form 4)4 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
- Chairman and CEO Yang Dajun converted options into 188,321 units of Ordinary Shares, increasing direct ownership by 9% to 1,193,569 units (SEC Form 4)4 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)
- SEC Form 4 filed by Misra Veet4 - ASCENTAGE PHARMA GROUP INTERNATIONAL (0002023311) (Issuer)